Here, we find that low expression of IL1RN in purified blasts correlated with negative prognosis in a publicly available big cohort of 381 global AML patients, and from those in 164 M4-M5 AML patients, at diagnosis time23–25 as well as in matched-pair diagnosis-relapsed AML patients26. This evidence concerns the gene IL1RN and acute myeloid leukemia.